{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:12:05Z","timestamp":1761052325838,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"crossref","award":["NCT01344096"],"award-info":[{"award-number":["NCT01344096"]}],"id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bcmd.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T12:48:52Z","timestamp":1431175732000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Re-evaluation of bone pain in patients with type 1 Gaucher disease suggests that bone crises occur in small bones as well as long bones"],"prefix":"10.1016","volume":"60","author":[{"given":"Hagit N.","family":"Baris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Weisz Hubshman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Bar-Sever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liora","family":"Kornreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Shkalim Zemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.05.003_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"issue":"9645","key":"10.1016\/j.bcmd.2015.05.003_bb0010","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0015","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0020","first-page":"273","article-title":"Gaucher disease: insights from a rare Mendelian disorder","volume":"77","author":"Sidransky","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0025","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1399-0004.2007.00811.x","article-title":"Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease","volume":"71","author":"Weinreb","year":"2007","journal-title":"Clin. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2015.05.003_bb0030","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2106\/00004623-199173040-00006","article-title":"Bone scans in the diagnosis of bone crisis in patients who have Gaucher disease","volume":"73","author":"Katz","year":"1991","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-0004.2007.00769.x","article-title":"The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease","volume":"71","author":"Charrow","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/bcmd.1998.0195","article-title":"Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease","volume":"24","author":"Cohen","year":"1998","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/adc.75.3.218","article-title":"Effective treatment of painful bone crises in type I Gaucher's disease with high dose prednisolone","volume":"75","author":"Cohen","year":"1996","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1542\/peds.2007-2144","article-title":"Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1","volume":"122","author":"Andersson","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2015.05.003_bb0075","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75","author":"Poll","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0080","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2106\/00004623-198769090-00009","article-title":"Fractures in children who have Gaucher disease","volume":"69","author":"Katz","year":"1987","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0085","first-page":"593","article-title":"Bone crisis in Gaucher disease\u2014an update","volume":"26","author":"Yosipovitch","year":"1990","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0090","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3324\/haematol.2009.008078","article-title":"Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project","volume":"94","author":"Giraldo","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00223-008-9143-4","article-title":"Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat","volume":"83","author":"Mikosch","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0100","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.clinthera.2007.08.006","article-title":"Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies","volume":"29","author":"Pastores","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bcmd.2014.04.002","article-title":"Eliglustat, an investigational oral therapy for Gaucher disease type 1: s 2 trial results after 4years of treatment","volume":"53","author":"Lukina","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"issue":"10","key":"10.1016\/j.bcmd.2015.05.003_bb0110","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00256-014-1891-9","article-title":"Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat","volume":"43","author":"Kamath","year":"2014","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0115","first-page":"793","article-title":"Skeletal involvement in Gaucher disease","volume":"10","author":"Elstein","year":"1997"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0363-5023(93)90057-A","article-title":"Upper limb involvement in patients with Gaucher's disease","volume":"18","author":"Katz","year":"1993","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/107110079902000206","article-title":"Involvement of the foot and ankle in patients with Gaucher disease","volume":"20","author":"Katz","year":"1999","journal-title":"Foot Ankle Int."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0002-9610(05)80902-X","article-title":"Long-term follow-up of partial splenectomy in Gaucher's disease","volume":"164","author":"Cohen","year":"1992","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2214\/AJR.07.3550","article-title":"Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease","volume":"191","author":"DeMayo","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0002-9378(95)91494-3","article-title":"Gynecologic and obstetric aspects of Gaucher's disease: a survey of 53 patients","volume":"172","author":"Granovsky-Grisaru","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bcmd.2009.04.003","article-title":"The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)","volume":"43","author":"Zimran","year":"2009","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1542\/peds.96.4.629","article-title":"Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase","volume":"96","author":"Rosenthal","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0165","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/qjmed\/hci144","article-title":"Bone crisis in stable Gaucher's disease","volume":"98","author":"P\u00e9rez-Calvo","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00194240","article-title":"Hemorrhage associated with \u201cbone crisis\u201d in Gaucher's disease identified by magnetic resonance imaging","volume":"20","author":"Horev","year":"1991","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0175","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1172\/JCI113431","article-title":"Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition","volume":"81","author":"Okusawa","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0180","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1172\/JCI110363","article-title":"Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures","volume":"68","author":"Gery","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0185","first-page":"260","article-title":"Managing Gaucher","volume":"2","author":"Cohen","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2015.05.003_bb0190","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1259\/bjr.75.suppl_1.750013","article-title":"Imaging and quantifying skeletal involvement in Gaucher disease","volume":"75","author":"Maas","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0195","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging\u2014initial experience","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.bcmd.2015.05.003_bb0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s002560100375","article-title":"Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results","volume":"30","author":"Poll","year":"2001","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/bcmd.1998.0197","article-title":"Reply to a commentary by Elstein et al. on a paper by Cohen IJ et al. BCMD. 24 (1998) 296\u2013302","volume":"24","author":"Cohen","year":"1998","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2015.05.003_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","article-title":"Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring","volume":"31","author":"Cox","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"author":"European Medicines Agency (EMA)","key":"10.1016\/j.bcmd.2015.05.003_bb0225"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:32:44Z","timestamp":1761049964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"alternative-id":["S1079979615000911"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluation of bone pain in patients with type 1 Gaucher disease suggests that bone crises occur in small bones as well as long bones","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}